198 related articles for article (PubMed ID: 38005183)
21. Genome-wide mutagenesis and multi-drug resistance in American trypanosomes induced by the front-line drug benznidazole.
Campos MC; Phelan J; Francisco AF; Taylor MC; Lewis MD; Pain A; Clark TG; Kelly JM
Sci Rep; 2017 Oct; 7(1):14407. PubMed ID: 29089615
[TBL] [Abstract][Full Text] [Related]
22. Novel 3-nitro-1H-1,2,4-triazole-based amides and sulfonamides as potential antitrypanosomal agents.
Papadopoulou MV; Bloomer WD; Rosenzweig HS; Chatelain E; Kaiser M; Wilkinson SR; McKenzie C; Ioset JR
J Med Chem; 2012 Jun; 55(11):5554-65. PubMed ID: 22550999
[TBL] [Abstract][Full Text] [Related]
23. Nitrotriazole-Based Compounds as Antichagasic Agents in a Long-Treatment
Papadopoulou MV; Bloomer WD; Rosenzweig HS; Mazzeti AL; Gonçalves KR; Mendes PF; Bahia MT
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28242662
[TBL] [Abstract][Full Text] [Related]
24. New Imidazole-Based Compounds Active Against Trypanosoma cruzi.
Adeyemi OS; Molina MT; Eseola AO; Fonseca-Berzal C; Gómez-Barrio A
Comb Chem High Throughput Screen; 2017; 20(1):20-24. PubMed ID: 28071587
[TBL] [Abstract][Full Text] [Related]
25. In vitro and in vivo studies of the antiparasitic activity of sterol 14α-demethylase (CYP51) inhibitor VNI against drug-resistant strains of Trypanosoma cruzi.
Soeiro Mde N; de Souza EM; da Silva CF; Batista Dda G; Batista MM; Pavão BP; Araújo JS; Aiub CA; da Silva PB; Lionel J; Britto C; Kim K; Sulikowski G; Hargrove TY; Waterman MR; Lepesheva GI
Antimicrob Agents Chemother; 2013 Sep; 57(9):4151-63. PubMed ID: 23774435
[TBL] [Abstract][Full Text] [Related]
26. Activation of benznidazole by trypanosomal type I nitroreductases results in glyoxal formation.
Hall BS; Wilkinson SR
Antimicrob Agents Chemother; 2012 Jan; 56(1):115-23. PubMed ID: 22037852
[TBL] [Abstract][Full Text] [Related]
27. 1,3-Thiazole derivatives as privileged structures for anti-Trypanosoma cruzi activity: Rational design, synthesis, in silico and in vitro studies.
Cox Holanda de Barros Dias M; Souza Barbalho M; Bezerra de Oliveira Filho G; Veríssimo de Oliveira Cardoso M; Lima Leite AC; da Silva Santos AC; Cristovão Silva AC; Accioly Brelaz de Castro MC; Maria Nascimento Moura D; Gomes Rebello Ferreira LF; Zaldini Hernandes M; de Freitas E Silva R; Rêgo Alves Pereira V
Eur J Med Chem; 2023 Sep; 257():115508. PubMed ID: 37267753
[TBL] [Abstract][Full Text] [Related]
28. Silver and copper-benznidazole derivatives as potential antiparasitic metallodrugs: Synthesis, characterization, and biological evaluation.
de Souza CC; de Azevedo-França JA; Barrias E; Cavalcante SCF; Vieira EG; Ferreira AMDC; de Souza W; Navarro M
J Inorg Biochem; 2023 Feb; 239():112047. PubMed ID: 36428157
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of 2-hydroxy-3-phenylsulfanylmethyl-[1,4]-naphthoquinone derivatives against different Trypanosoma cruzi discrete type units: Identification of a promising hit compound.
Lara LS; Moreira CS; Calvet CM; Lechuga GC; Souza RS; Bourguignon SC; Ferreira VF; Rocha D; Pereira MCS
Eur J Med Chem; 2018 Jan; 144():572-581. PubMed ID: 29289882
[TBL] [Abstract][Full Text] [Related]
30. Identification of Novel Functionalized Carbohydrazonamides Designed as Chagas Disease Drug Candidates.
do Nascimento MSS; Câmara VRF; da Costa JS; Barbosa JMC; Lins ASM; Salomão K; de Castro SL; Carvalho SA; da Silva EF; Fraga CAM
Med Chem; 2020; 16(6):774-783. PubMed ID: 31244442
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and in vitro and in silico studies of 1H- and 2H-1,2,3-triazoles as antichagasic agents.
Silva TB; Ji KNK; Petzold Pauli F; Galvão RMS; Faria AFM; Bello ML; Resende JALC; Campos VR; Forezi LDSM; da Silva FC; Faria RX; Ferreira VF
Bioorg Chem; 2021 Nov; 116():105250. PubMed ID: 34469833
[TBL] [Abstract][Full Text] [Related]
32. Synthesis, Design, and Structure-Activity Relationship of a Benzenesulfonylpiperazine Series against Trypanosoma cruzi.
Cassiano Martinho AC; de Melo Resende D; Landin ES; Dit Lapierre TJWJ; Bernardes TCD; Martins LC; Ferreira RS; Murta SMF; de Oliveira Rezende Júnior C
ChemMedChem; 2022 Oct; 17(19):e202200211. PubMed ID: 35993440
[TBL] [Abstract][Full Text] [Related]
33. Design, synthesis and molecular docking studies of novel N-arylsulfonyl-benzimidazoles with anti Trypanosoma cruzi activity.
Miana GE; Ribone SR; Vera DMA; Sánchez-Moreno M; Mazzieri MR; Quevedo MA
Eur J Med Chem; 2019 Mar; 165():1-10. PubMed ID: 30641409
[TBL] [Abstract][Full Text] [Related]
34. Antitrypanosomal Activity of Sterol 14α-Demethylase (CYP51) Inhibitors VNI and VFV in the Swiss Mouse Models of Chagas Disease Induced by the Trypanosoma cruzi Y Strain.
Guedes-da-Silva FH; Batista DG; Da Silva CF; De Araújo JS; Pavão BP; Simões-Silva MR; Batista MM; Demarque KC; Moreira OC; Britto C; Lepesheva GI; Soeiro MN
Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28167559
[TBL] [Abstract][Full Text] [Related]
35. Effect of capsaicin on the protozoan parasite Trypanosoma cruzi.
Valera-Vera EA; Reigada C; Sayé M; Digirolamo FA; Galceran F; Miranda MR; Pereira CA
FEMS Microbiol Lett; 2020 Dec; 367(23):. PubMed ID: 33232444
[TBL] [Abstract][Full Text] [Related]
36. Identification of Inhibitors to
Matutino Bastos T; Botelho Pereira Soares M; Haddad Franco C; Alcântara L; Antonini L; Sabatino M; Mautone N; Holanda Freitas-Junior L; Moraes CB; Ragno R; Rotili D; Schenkman S; Mai A; Silvio Moretti N
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32455951
[TBL] [Abstract][Full Text] [Related]
37. Synthesis, structure-activity relationship and trypanocidal activity of pyrazole-imidazoline and new pyrazole-tetrahydropyrimidine hybrids as promising chemotherapeutic agents for Chagas disease.
Monteiro ME; Lechuga G; Lara LS; Souto BA; Viganó MG; Bourguignon SC; Calvet CM; Oliveira FOR; Alves CR; Souza-Silva F; Santos MS; Pereira MCS
Eur J Med Chem; 2019 Nov; 182():111610. PubMed ID: 31434040
[TBL] [Abstract][Full Text] [Related]
38. Experimental models in Chagas disease: a review of the methodologies applied for screening compounds against Trypanosoma cruzi.
Fonseca-Berzal C; Arán VJ; Escario JA; Gómez-Barrio A
Parasitol Res; 2018 Nov; 117(11):3367-3380. PubMed ID: 30232605
[TBL] [Abstract][Full Text] [Related]
39. Putative Role of the Aldo-Keto Reductase from Trypanosoma cruzi in Benznidazole Metabolism.
Garavaglia PA; Laverrière M; Cannata JJ; García GA
Antimicrob Agents Chemother; 2016 May; 60(5):2664-70. PubMed ID: 26856844
[TBL] [Abstract][Full Text] [Related]
40. Candimine from Hippeastrum escoipense (Amaryllidaceae): Anti-Trypanosoma cruzi activity and synergistic effect with benznidazole.
Ortiz JE; Piñeiro M; Martinez-Peinado N; Barrera P; Sosa M; Bastida J; Alonso-Padilla J; Feresin GE
Phytomedicine; 2023 Jun; 114():154788. PubMed ID: 37037085
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
